Surface bacterial antigen CS31A as a tool to design new recombinant vaccines displaying heterologous antigenic determinants.
Martin
C
C
INRA-Theix, laboratoire de microbiologie, Saint-Genès-Champanelle, France.
Girardeau
J P
JP
Der Vartanian
M
M
Méchin
M C
MC
Bousquet
F
F
Bertin
Y
Y
Laude
H
H
Contrepois
M
M
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D015478:Antigens, Heterophile / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology*; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology; D015195:Drug Design; D000939:Epitopes / Q000276:immunology*; D004926:Escherichia coli; D029968:Escherichia coli Proteins; D051379:Mice; D014614:Vaccines, Synthetic / Q000276:immunology* / Q000627:therapeutic use
D000942:Antigens, Bacterial; D015478:Antigens, Heterophile; D000954:Antigens, Surface; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D000939:Epitopes; D029968:Escherichia coli Proteins; D014614:Vaccines, Synthetic; C071730:clpG protein, E coli